Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Sab Biotherapeutics Inc (NQ: SABS ) 2.660 -0.040 (-1.48%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,822 Open 2.710 Bid (Size) 2.650 (1) Ask (Size) 2.700 (3) Prev. Close 2.700 Today's Range 2.657 - 2.870 52wk Range 2.160 - 10.50 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News SABS Stock Earnings: SAB Biotherapeutics Beats EPS for Q2 2024 August 09, 2024 SABS stock results show that SAB Biotherapeutics beat analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace SAB BIO Announces Second Quarter 2024 Financial Results and Provides Company Updates August 08, 2024 From SAB Biotherapeutics, Inc. Via GlobeNewswire Performance YTD -62.00% -62.00% 1 Month -6.99% -6.99% 3 Month -2.21% -2.21% 6 Month -46.69% -46.69% 1 Year -60.30% -60.30% More News Read More SAB BIO Announces Founding of Clinical Advisory Board to Guide the Development of SAB-142 for Type 1 Diabetes August 05, 2024 From SAB Biotherapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's Pre-Market Session June 20, 2024 Via Benzinga SAB BIO Appoints Lucy To as Chief Financial Officer July 31, 2024 From SAB Biotherapeutics, Inc. Via GlobeNewswire SAb Biotherapeutics Rebrands as SAB BIO June 20, 2024 From SAB Biotherapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's After-Market Session June 19, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session June 18, 2024 Via Benzinga SAB Biotherapeutics to Present at the American Diabetes Association 84th Scientific Sessions June 18, 2024 From SAB Biotherapeutics, Inc. Via GlobeNewswire SAB Biotherapeutics Announces Departure of Chief Financial Officer May 30, 2024 From SAB Biotherapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's Intraday Session May 23, 2024 Via Benzinga SABS Stock Earnings: SAB Biotherapeutics Misses EPS for Q1 2024 May 21, 2024 Via InvestorPlace FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics May 21, 2024 From SAB Biotherapeutics, Inc. Via GlobeNewswire SAB Biotherapeutics Announces Q1 2024 Financial Results and Provides Company Updates May 20, 2024 From SAB Biotherapeutics, Inc. Via GlobeNewswire SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors May 06, 2024 From SAB Biotherapeutics, Inc. Via GlobeNewswire SAB Biotherapeutics Provides SAB-142 Trial Update April 16, 2024 From SAB Biotherapeutics, Inc. Via GlobeNewswire SAB Biotherapeutics to Present at INNODIA Annual Meeting April 08, 2024 From SAB Biotherapeutics, Inc. Via GlobeNewswire SAB Biotherapeutics to Present at the Needham Virtual Healthcare Conference April 04, 2024 From SAB Biotherapeutics, Inc. Via GlobeNewswire SAB Biotherapeutics Announces Clinical Partnership with Naval Medical Research Center to Advance Potential Influenza Treatment March 25, 2024 From SAB Biotherapeutics, Inc. Via GlobeNewswire SAB Biotherapeutics to Present at the BIO CEO & Investor Conference February 23, 2024 From SAB Biotherapeutics, Inc. Via GlobeNewswire SAB Biotherapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference February 08, 2024 From SAB Biotherapeutics, Inc. Via GlobeNewswire SAB Biotherapeutics Announces Executive Leadership Change February 02, 2024 From SAB Biotherapeutics, Inc. Via GlobeNewswire SAB Biotherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement January 23, 2024 From SAB Biotherapeutics, Inc. Via GlobeNewswire Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session January 05, 2024 Via Benzinga Cal-Maine Foods, UniFirst And 3 Stocks To Watch Heading Into Wednesday January 03, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.